How Will Physicians Respond to the Next Influenza Pandemic?

被引:20
|
作者
Fedson, David S.
机构
关键词
pandemic influenza; statins; immunomodulatory agents; public health; RECEPTOR BLOCKERS; HUMAN INFECTIONS; VIRUS; MORTALITY; STATINS; SURVIVAL; A(H7N9); VACCINE; METABOLISM; CHALLENGES;
D O I
10.1093/cid/cit695
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The emergence of the H7N9 virus in China is another reminder of the threat of a global influenza pandemic. Many believe we could confront a pandemic by expanding our capacity to provide timely supplies of affordable pandemic vaccines and antiviral agents. Experience in 2009 demonstrated that this cannot and will not be done. Consequently, physicians may have little more to offer their patients than they had in the 1918 pandemic. Fortunately, several modern drugs (eg, statins, angiotensin II receptor blockers, angiotensin-converting enzyme inhibitors) can modify the host response to inflammatory illness, and laboratory and clinical studies suggest they might be used to treat pandemic patients. Unfortunately, little attention has been given to the research needed to support their use in patient care. There is no guarantee these drugs will work, but physicians will never know unless those responsible for pandemic preparedness recognize and act on the extraordinary possibility that they might save lives.
引用
收藏
页码:233 / 237
页数:5
相关论文
共 50 条